|
|
|
Prof. Dr. Cihangir EREM
Academic Title
Prof. Dr.
Foreign language
İngilizce
Place of Birth - Date
Ünye, 01.03.1960
Working hours
Weekdays: 08:00-17:00
Saturday: 08:00-14:00
Education
1985 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi’ni bitirdi. 1988–1992 KTÜ Tıp Fakültesinde İç Hastalıkları Uzmanı oldu. 1996-1998 İstanbul Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Endokrinoloji, Metabolizma ve Beslenme Bilim Dalı’nda 2 yıl süreli yan dal uzmanlık eğitimini tamamladı. 2000-2005 KTÜ Tıp Fakültesinde Tıbbi Biyokimya Doktorasını tamamladı.
Affiliates
Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD) Üyeliği. TEMD Tiroid ve Obezite, Dislipidemi, Hipertansiyon Çalışma Grubu Üyeliği. Diyabet, Obezite ve Beslenme Derneği Üyeliği. Türkiye Klinikleri Endokrinoloji Dergisi Yayın Kurulu Üyeliği. Nobel Medikus Dergisi Yayın Kurulu Üyeliği. American Endocrine Society Üyeliği.
Professional Career
Çalıştığı Kurumlar: 1985-1988 Mecburi Hizmet (Mardin/Mazıdağı Merkez Sağlık Ocağı Tabibi ve Mardin Sağlık Müdür Yardımcılığı) 1988-1992 KTÜ Tıp Fakültesi İç Hastalıkları ABD Araştırma Görevlisi 1993-1996 KTÜ Tıp Fakültesi İç Hastalıkları Anabilim Dalı’nda Y. Doçent 1996-2002 KTÜ Tıp Fakültesi İç Hastalıkları Anabilim Dalı’nda Doçent 2003-2016 KTÜ Tıp Fakültesi İç Hastalıkları Anabilim Dalı’nda Profesör 01.08.2017 tarihinde KTÜ Tıp Fakültesi’nden emekli oldu. Verdiği Dersler: Endokrin Hastaya Yaklaşım Hipotalamus ve Hipofiz Hastalıkları Adrenal Medülla Hastalıkları ve Feokromositoma Adrenal Korteks Hastalıkları Obezite ve Tedavisi Hipofiz Bezi Hastalıkları Tiroid Bezi Hastalıkları Hipertiroidi ve Tedavisi Cilt ve Mukoza Muayenesi Bilimsel Yayınlar: Yayınlanmış 120’ın üzerinde uluslararası makale ve 120’nin üzerinde ulusal makale, ulusal ve uluslararası bildiri Uluslararası Bilimsel Atıf Sayısı: 11.676 (Google Scholar), 6317 (Scopus), 7059 (Web of Science) H Index: 39 (Google Scholar), 31 (Scopus), 30 (Web of Science)
Prof. Dr. Cihangir EREM, Doğu Karadeniz Bölgesinin ilk Endokrinoloji ve Metabolizma Hastalıkları Uzmanı ve profesörüdür, 1995 yılından itibaren Doğu Karadeniz Bölgesinde ilk defa Diyabetes Mellitus (Şeker Hastalığı), Hipertansiyon (Yüksek Tansiyon), Hiperlipidemi (Kanda Kolesterol Yüksekliği) ve Guatr hastalıklarının toplumdaki sıklığını ve risk faktörlerini, kurucusu ve yöneticisi olduğu araştırma grubu ile (Trabzon Endocrinological Study Group) araştırmıştır. 20 yıldır devam eden bu araştırmalar yurt içi ve yurt dışı (uluslararası) ciddi ve saygın bilimsel dergilerde yayınlamıştır. Kendi branşında ülkemiz ve üniversitesi adına bilinen ve tanınan bir bilim insanı olmasına neden olmuştur. Yapılan bu araştırmalar aynı konular üzerinde araştırmalar yapan ABD ve İngiltere’deki araştırmacıların dikkatini çekmiş ve KTÜ Tıp Fakültesi Endokrin ve Metabolizma hastalıkları kliniğine bilimsel işbirliği (collaboration) teklifi yapmışlar, böylece Endokrin ve Metabolizma hastalıkları kliniği uluslararası bilimsel araştırma ağları olan NCD Risk Factor Collaboration (NCD-RisC) ve Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating gruplarına dahil olmuştur. Son 10 yıldır ABD Harvard Tıp Fakültesi (Dünyanın en yüksek bilimsel düzeydeki Tıp Fakültesi) ve İngiltere Kraliyet Londra Üniversitesi’ndeki (Imperial London College) bilim adamları ile (Bin Zhou, Danaei Goardz, Majid Ezzati, Singh GM, Finucane MM, Mariachiara Di Cesare) yukarıda adı geçen, guatr dışındaki diğer hastalıklarla ilgili bilimsel işbirliği devam etmektedir. Bu araştırmalar binlerce tıp dergisi arasında bilimsel düzey açısından dünyanın 2. sıradaki dergisi olan Lancet adlı dergide (SCI, IF: 53.254) 2011 yılından itibaren yayınlanmış ve yayınlanmaya devam etmektedir. Prof. Dr. Cihangir EREM, KTÜ’den emekli olmadan önce akademik performans sıralamasında (uluslararası indekslere giren dergilerde yayınlanan makale sayısı) KTÜ’deki 1040 öğretim üyesi arasında ilk sıralarda ve Tıp Fakültesindeki 250 öğretim üyesi arasında 1. sırada yer almıştır. Resume
YAYIN LİSTESİ I-ULUSLARARASI MAKALELER 1- NCD Risk Factor Collaboration (NCD-RisC). Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature. 2019;569 (7755): 260-264 2 - NCD Risk Factor Collaboration (NCD-RisC). Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol. 2018; 47(3): 872–883i. 3 - NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017; 390(10113):2627-2642. 4 - Türk A, Mollamehmetoğlu S, Alver A, Menteşe A, Nuhoğlu İ, Erem C, İmamoğlu Hİ. The Relationship between Serum Carbonic Anhydrase I-II Autoantibody Levels and Diabetic Retinopathy in Type 1 Diabetes Patients. Turk J Ophthalmol. 2017; 47(2):85-88. 5 - NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017; 389(10064): 37-55. 6 - NCD Risk Factor Collaboration (NCD-RisC). A century of trends in adult human height. Elife. 2016; 5 pii: e13410.7 Erem C, Suleyman AK, Civan N, Mentese A, Nuhoglu İ, Uzun A, Coskun H, Deger O. The effect of L-thyroxine replacement therapy on ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hypothyroidism. Endocr Res. 2016; 41(4): 350-360. 8 - NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387(10027): 1513-30. 9 - NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016; 387(10026):1377-1396 10 - Erem C, Civan N, Coskun H, Mentese A, Suleyman AK, Altay DU, Akgul Z, Deger O. Signal peptide-CUB-EGF domain-containing protein 1 (SCUBE1) levels in patients with overt and subclinical hyperthyroidism: effects of treatment. Clin Endocrinol(Oxf). 2016; 84(6): 919-24. 11 - Erem C. Prevalence of Overweight and Obesity in Turkey. IJC Metabolic & Endocrine. 2015; 8: 38-41. 12 - NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol. 2015; 3(8):624-37. 13 - Erem C, Kuzu UB, Deger O, CanG. Prevalence of gestational diabetes mellitus and associated risk factors in Turkish women: The Trabzon GDM Study. Archives of Medical Science. 2015; 11(4): 724-735. 14 - Erem C, Suleyman AK, Civan N, Mentese A, Nuhoglu I, Uzun A, Ersoz HO, Deger O. Ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress. Endocr J. 2015; 62(6): 493-501. 15 - Usta A, Alhan E, Cinel A, Türkyılmaz S, Erem C. A 20-Year Study on 190 Patients With Primary Hyperparathyroidism in a Developing Country: Turkey Experience. Int Surg. 2015; 100: 648-55. 16 - Ilter A, Kırış A, Kaplan S, Kutlu M, Sahin M, Erem C, Civan N, Kangül F. Atrial conduction times and left atrium mechanical functions in patients with active acromegaly. Endocrine. 2015; 48(2):653-60. 17 - Kural B, Değer O, Erem C, Balaban Yücesan F, Aliyazicioğlu R, Barlak Y. Is the combined use of insulin resistance indices, including adipokines, more reliable in metabolic syndrome? Turk J Med Sci. 2014;44(6):1021-8. 18 - Civan N, Erem C, Coskun H, Kocak M, Nuhoglu I, Ersoz HO. Hypoparathyroidism, deafness, and renal dysplasia. Acta Endocrinol-Bucharest. 2014; 10(4): 687-692. 19 - Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014; 2(8): 634-47. 20 - Erem C, Fidan M, Civan N, Cobanoglu U, Kangul F, Nuhoglu I, Alhan E. Hormone-secreting large adrenal ganglioneuroma in an adult patient: a case report and review of literature. Blood Press. 2014; 23(1):64-9. 21 - Erden ES, Genc S, Motor S, Ustun I, Ulutas KT, Bilgic HK, Oktar S, Sungur S, Erem C, Gokce C. Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome. Endocrine. 2014; 45(2):311-8. 22 - Kocak M, Erem C, Deger O, Topbas M, Ersoz HO, Can E. Current prevalence of goiter determined by ultrasonography and associated risk factors in a formerly iodine-deficient area of Turkey. Endocrine. 2014; 47 (1): 290-98. 23 - Erem C, Civan N, Fidan M, Cobanoglu U, Kangül F, Fural AM. Warthin-Like Papillary Thyroid Carcinoma: Report of a New Case. Acta Endocrinol-Bucharest. 2014, 10 (2): 293-298. 24 - Erem C, Civan N., Fidan M., Cobanoglu U., Kangül F., Ersoz H.O., Alhan E. Composite Adrenal Pheochromocytoma-Ganglioneuroma in an Adult Patient. Acta Endo (Buc) 2014, 10 (1): 140-149. 25 - Erem C, Ozbas HM, Nuhoglu I, Deger O, Civan N, Ersoz HO. Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2014 May;122(5):295-302. 26 - Erem C. Update on idiopathic hirsutism: diagnosis and treatment. Acta Clin Belg. 2013 Jul-Aug;68(4):268-74. 27 - Kural BV, Deger, O, Erem C et al. Sequence Variant in the LPIN1 gene in Patientswith Metabolic Syndrome. Turk J Biochem. 2013; 38 (3): 280-85. 28 - Deger O, Yandi YE, Ayvaz M, Erem C, Hacıhasanoğlu AB. Polymorphisms in ABC transporters (ABCA1 and ABCC8) in metabolic syndrome. Turk J Med Sci. 2013; 43 (2): 214-221. 29 - Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F,Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008 Circulation. 2013;127(14):1493-502 30 - Kırış A, Erem C, Turan OE, Civan N, Kırış G, Nuhoğlu I, Ilter A, Ersöz HO, Kutlu M. Left ventricular synchronicity is impaired in patients with active acromegaly. Endocrine. 2013 Aug;44(1):200-6. 31 - Erem C, Civan N. Extensive cerebral calcification and pulmonary bullae in a patient with ehlers-Danlos syndrome. Acta Endocrinol-Bucharest. 2012; 8(4): 645-650. 32 - Erem C, Ucuncu O, Nuhoglu I, Turkyilmaz S, Yildiz K, Civan N, Akcay M. Large Adrenocortical Oncocytoma with Uncertain Malignant Potential: Report of a New Case and review of the Literature. Acta Endocrinol-Bucharest. 2012; 8: 295-306. 33 - Kırış A, Erem C, Kırış G, Nuhoğlu I, Karaman K, Civan N, Orem C, Durmuş I, Kutlu M. The assessment of left ventricular systolic asynchrony in patients with primary hyperparathyroidism. Echocardiography. 2011 Oct;28(9):955-60. 34 - Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C. Correspondence. Retina. 2011 Sep 12 [Epub ahead of print] 35 - Sonmez B, Erem C, Dogan I, Ersoz HO, Sonmez M. Efficacy of low and high fixed dose radioactive iodine therapy in patients with toxic nodular goiter. Minerva Endocrinol. 2011 Jun;36(2):117-21. 36 - Fidan E, Onder Ersoz H, Yilmaz M, Yilmaz H, Kocak M, Karahan C, Erem C. The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol. 2011 Dec;48 (4):297-302. 37 - Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, Farzadfar F, Stevens GA, Lim SS, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet. 2011 Feb 12;377(9765):568-77. 39 - Erem C. Thyroid disorders and hypercoagulability. Semin Thromb Hemost. 2011 Feb;37(1):17-26. 40 - Kırış A, Erem C, Kırış G, Koçak M, Gedikli O, Nuhoğlu I, Kutlu M, Kaplan T, Gökçe M, Celik S. Intra-left ventricular systolic asynchrony in patients with overt hyperthyroidism. Endocrine. 2010 Oct;38(2):283-8. 41 - Erem C, Kocak M, Nuhoglu I, Yılmaz M, Ucuncu O. Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma. Clin Endocrinol (Oxf). 2010 Oct;73(4):502-7. 42 - Erem C, Kocak, M; Ersoz, HO, et al. Hypertension, Diabetes, Hypokalemia, and Metabolic Alkalosis Cushing Syndrome Secondary to Ectopic Adrenocorticotropic Hormone Secretion From Prostate Adenocarcinoma. Endocrinologist. 2010; 20: 211- 13 43 - Erem C. A Case of Pituitary Hyperplasia Secondary to Primary Hypothyroidism Presenting With Irregular Menses, Galactorrhea, and Hyperprolactinemia. Endocrinologist. 2010; 20: 168-70. 44 - Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz HO. Increased thrombin- activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism. Endocrine. 2009; 36: 473-78. 45 - Erem C, Kocak M, Nuhoglu I, Cobanoglu U, Ucuncu O, Okatan BK. Primary thyroid paraganglioma presenting with double thyroid nodule: a case report. Endocrine. 2009;36: 368-71. 46 - Ukinc K, Eminagaoglu S, Ersoz HO, Erem C, Karahan C, Hacihasanoglu AB, Kocak M. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine. 2009; 36: 425-32. 47 - Kaplan S, Kırış A, Erem C, Kaplan T, Kırış G, Gedikli O, Koçak M, Baykan M, Celik S. Assessment of Left Ventricular Systolic Asynchrony in Patients with Clinical Hypothyroidism. Echocardiography. 2010 Feb;27(2):117-22. 48 - Unluhizarci K, Kula M, Dundar M, Tanriverdi F, Israel S, Colak R, Dokmetas HS, Atmaca H, Bahceci M, Balci MK, Comlekci A, Bilen H, Akarsu E, Erem C, Kelestimur F. The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism. Gynecol Endocrinol. 2010; 26: 139-143. 49 - Ukinc K, Ersoz HO, Karahan C, Erem C, Eminagaoglu S, Hacihasanoglu AB, Yilmaz M, Kocak M. Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine. 2009 Oct;36(2):255-61. 50 - Erem C, Nuhoglu I, Yilmaz M, Kocak M, Demirel A, Ucuncu O, Onder Ersoz H. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. J Endocrinol Invest. 2009 Feb;32(2):169-74. 51 - Erem C, Ucuncu O, Nuhoglu I, Cinel A, Cobanoglu U, Demirel A, Koc E, Kocak M, Guvendi GF. Adrenal ganglioneuroma: report of a new case. Endocrine. 2009 Jun;35(3):293-6. 52 - Erem C. Coagulation and fibrinolysis in thyroid dysfunction. Endocrine. 2009 Aug;36 (1):110-8. 53 - Baykan M, Erem C, Gedikli O, Hacihasanoglu A, Erdogan T, Kocak M, Kaplan S, Korkmaz L, Celik S. Impairment in flow-mediated vasodilatation of the brachial artery in acromegaly. Med Princ Pract. 2009;18(3):228-32. 54 - Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB, Karti SS. Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients. Endocrine. 2009 Jun;35(3):380-8. 55 - Erem C, Kocak M, Nuhoglu I, Yilmaz M, Ucuncu O. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin- activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism. Eur J Endocrinol. 2009 May;160(5):863-8. 56 - Alver, A, Menteşe A, Erem C, Değer, Koçak M, Keha E. Serum carbonic anhydrase autoantibodies in metabolic syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2009: 3 (4): 211-13. 57 - Erem C, Nuhoglu I, Kocak M, Yilmaz M, Sipahi ST, Ucuncu O, Ersoz HO.Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI. Endocrine. Jun;33(3):270-6. 58 - Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB.Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome. Endocrine. 2009 Feb;35(1):123-9. 59 - Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine. 2008 Aug-Dec;34(1-3):36-51. 60 - Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz HO.Increased thrombin- activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. Endocrine. 2009 Feb;35(1):75-80. 61 - Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health (Oxf). 2008; 31(1):47-58. 62 - Erem C, Kocak M, Hacihasanoglu A, Yilmaz M. Blood coagulation and fibrinolysis in male patients with hypogonadotropic hypogonadism: plasma factor V and factor X activities increase in hypogonadotropic hypogonadism. J Endocrinol Invest. 2008 Jun;31(6):537-41. 63 - Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO. Blood Coagulation, Fibrinolysis and Lipid Profile in Patients with Primary Hyperparathyroidism: Increased Plasma Factor VII and X Activities and D-Dimer Levels. Exp Clin Endocrinol Diabetes. 2008; 116(10):619-24. 64 - Ersoz S, Sert H, Yandi M, Erem C, Mungan S, Ersoz HO, Cobanoglu U, Hacihasanoglu A. The Significance Of Galectin-3 Expression in the Immunocytochemical Evaluation of Thyroid Fine Needle Aspiration Cytology. Pathol Oncol Res. 2008; 14(4):457-60. 65 - Erem C, Hacihasanoglu A, Deger O, Topbas M, Hosver I, Ersoz HO, Can G. Prevalence of Metabolic Syndrome and Associated Risk Factors Among Turkish Adults: Trabzon MetS Study. Endocrine. 2008; 33(1):9-20. 66 - Baykan M, Erem C, Gedikli O, Hacihasanoglu A, Erdogan T, Kocak M, Kaplan S,Kiriş A, Orem C, Celik S. Assessment of Left Ventricular Diastolic Function and Tei Index by Tissue Doppler Imaging in Patients with Cushing's Syndrome. Echocardiography. 2008 Feb;25(2):182-90. 67 - Baykan M, Erem C, Gedikli O, Hacıhasanoğlu A, Erdoğan T, Koçak M, Kaplan S, Kırış A, Celik S. Assessment of the Tei Index by Tissue Doppler Imaging in Patients with Acromegaly: Serum Growth Hormone Level Is Associated with the Tei Index. Echocardiography. 2008; 25: 374-380. 68 - Erem C, Kocak M, Cinel A, Ersoz HO, Reis A. Dopamine-secreting adrenal ganglioneuroma presenting with paroxysmal hypertension attacks. Saudi Med J. 2008 Jan;29(1):122-5. 69 - Ukinc K, Ersoz HO, Erem C, Hacihasanoglu A, Ersoz S, Buran M. Pachydermoperiostosis with gynecomastia and osteoporosis: a rare case with a rare presentation. Int J Clin Pract. 2007 Nov;61(11):1939-40. No abstract available. 70 - Baykan M, Erem C, Gedikli O, Hacihasanoglu A, Erdogan T, Kocak M, Durmuş I, Korkmaz L, Celik S. Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's Syndrome. Endocrine. 2007 Jun;31(3):300-4. 71 - Kaynar K, Ozkan G, Erem C, Gul S, Yilmaz M, Sonmez B, Ozdemir F, Ulusoy S. An unusual etiology of erythropoietin resistance: hyperthyroidism. 2007;29(6):759-61. PMID: 17763175 [PubMed - indexed for MEDLINE] 72 - Alver A, Mentese A, Karahan SC, Erem C, Keha EE, Arikan MK, Eminagaoglu MS, Deger O. Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease. Exp Clin Endocrinol Diabetes. 2007; 115: 287-91. 73 - Isik AC, Imamoglu M, Erem C, Sari A. Paragangliomas of the head and neck. Med Princ Pract. 2007; 16: 209-14. 74 - Baykan M, Erem C, Erdogan T, Ersoz HO, Gedikli O, Korkmaz L, Kucukosmanoglu M, Haclhasanoglu A, Kaplan S, Celik S. Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf). 2007; 66: 483-88. 75 - Baykan M, Erdogan T, Erem C, Hacihasanoglu A, Gedikli O, Kucukosmanoglu M, Celik S, Orem C. The relationship between flow-mediated dilatation and left ventricular function in type 2 diabetic patients with microalbuminuria. Endocrine. 2006; 30: 197-202. 76 - Erem C, Deger O, Ovali E, Barlak Y. The effects of royal jelly on autoimmunity in Graves' disease. Endocrine. 2006; 30: 175-83. 77 - Erem C, Onder Ersoz H, Ukinc K, Hacihasanoglu A, Alhan E, Cobanoglu U, Kocak, M, Erdol H. Neurofibromatosis type 1 associated with pheochromocytoma: a case report and a review of the literature. J Endocrinol Invest. 2007; 30: 59-64. 78 - Erem C, Ersoz HO, Ukinc K, Avunduk AM, Hacihasanoglu A, Kocak M. Acromegaly presenting with diabetic ketoacidosis, associated with retinitis pigmentosa and octreotide-induced bradycardia: a case report and a review of the literature. Endocrine. 2006; 30: 145-49. 79 - Baykan M, Erem C, Erdogan T, Hacihasanoglu A, Gedikli O, Kiris A, Kucukosmanoglu M, Ersoz HO, Celik S. Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging. 2007; 23: 323-28. 80 - Celik S, Erdogan T, Gedikli O, Kiris A, Erem C. Diagonal ear-lobe crease is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease. Atherosclerosis. 2007; 192: 428-31. 81 - Erem C, Hacihasanoglu A, Cinel A, Isik AC, Reis A, Sari A, Ersoz HO, Ukinc K. Carotid body tumors and adrenal pheochromocytomas in siblings of a Turkish family. Med Princ Pract. 2006;15: 396-400. 82 - Ersoz HO, Ukinc K, Kose M, Erem C, Gunduz A, Hacihasanoglu AB, Karti SS.Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int J Clin Pract. 2006; 60: 429-33. 83 - Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf). 2006; 64: 323-29. 84 - Isik AC, Erem C, Imamoglu M, Cinel A, Sari A, Maral G. Familial Paraganglioma Eur Arch Oto-Rhino-L. 2006 Jan;263(1):23-31. 85 - Erem C, Kocak M, Onder Ersoz H, Ersoz S, Yucel Y. Epinephrine-secreting cystic pheochromocytoma presenting with an incidentaladrenal mass: a case report and a review of the literature. Endocrine. 2005; 28: 225-30. 86 - Erem C, Hacihasanoglu A, Ersoz HO, Reis AK, Calik A, Ukinc K, Kocak M. Pheochromocytoma combinated with preclinical Cushing’s Syndrome in the same adrenal gland. J Endocrinol Invest. 2005; 28: 561-65. 87 - Erem C, Celik F, Reis AK, Hacihasanoglu A, Gör A. Large Adrenal Pseudocyst Presenting with Epigastric Distress and Abdominal Distention. Med Princ Pract. 2005; 14: 284-87. 88 - Erem C. Thyrotoxic hypokalemic periodic paralysis in a Turkish male with Graves' disease: a rare case report and review of the literature. Endocrine. 2005; 27: 63-65. 89 - Erem C, Yucel Y, Yasar Z, Reis AK, Kocak M, Hacihasanoglu A. Leukocytoclastic vasculitis: a rare manifestation of propylthiouracil hypersensitivity. Med Princ Pract. 2005; 14: 366-69. 90 - Sayarlioglu H, Erkoc R, Dogan E, Topal C, Algun E, Erem C, Atmaca H, Kocak E ,Yilmaz R, Erdol H, Cınal A. Nephropathy and retinopathy in type 2 diabetic patients living at moderately high altitude and sea level. Ren Fail. 2005; 27: 67-71. 91 - Erem C, Hacihasanoglu A, Celik S, Ovali E, Ersoz HO, Ukinc K, Değer O, Telatar M. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Princ Pract. 2005; 14: 22-30. 92 - Erem C, Hacihasanoglu A, Cinel A, Cobanoglu U, Ersoz HO, Ahmetoglu A, Ukinc K, Kocak M. Adrenal Black Adenoma Associated with Cushing’s Syndrome. Endocrine. 2004; 25: 253-58. 93 - Erem C, Hacihasanoglu A, Sari A, Reis A, Alhan E, Cobanoglu U, Ersoz HO, Ukinc K. Intrathyroidal papillary thyroid carcinoma presenting with a solitary brain metastasis. Endocrine. 2004; 25: 187-94. 94 - Erem C, Hacihasanoglu A, Sari A, Onder Ersoz H, Ukinc K, Fidan S. A Rare Case and a Rapid Tumor Response to Therapy: Dramatic Reduction in Tumor Size During Octreotide Treatment in a Patient with TSH-Secreting Pituitary Macroadenoma. Endocrine. 2004; 25: 141-46. 95 - Erem C, Kandemir N, Hacihasanoglu A, Ersoz HO, Ukinc K, Kocak M. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome. Endocrine. 2004; 25: 55-60. 96 - Ulusoy S, Ovali E, Aydin F, Erem C, Ozdemir F, Kaynar K. Hemostatic and fibrinolytic response to nasal desmopressin in hemodialysis patients. Med Princ Pract. 2004; 13: 340-45. 97 - Erem C, Arslan C, Hacihasanoglu A, Deger O, Topbas M, Ukinc K, Ersoz HO, Telatar M. Prevalence of obesity and associated risk factors in a Turkish population (Trabzon city, Turkey). Obes Res. 2004;12: 1117-27. 98 - Erem C, Hacihasanoglu A, Cinel A, Ersoz HO, Reis A, Sari A, Kose M, Ukinc K, Telatar M.Sphenoid sinus brown tumor, a mass lesion of occipital bone and hypercalcemia: an unusual presentation of primary hyperparathyroidism. Endocrinol Invest. 2004; 27: 366-69. 99 - Ersoz HO, Ukinc K, Baykan M, Erem C, Durmus I, Hacihasanoglu A, Telatar M. Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study. Int J Obes Relat Metab Disord. 2004; 28: 378-83. 100 - Erem C, Kavgaci H, Ersoz HO, Ukinç K, Hacıhasanoglu H, Kartı SS, Değer O, Telatar M. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract. 2003; 57: 78-81. 101 - Erem C, Algün E, Özbey N, Azezli A, Aral F, Orhan Y, Molvalılar S, Sencer E. Clinical and Laboratory Findings and Results of Therapy in 55 Patients with Cushing’s Syndrome. J Endocrinol Invest. 2003; 26: 65-72. 102 - Erem C, Cihanyurdu N, Deger O, Karahan C, Can G, Telatar M. Screening for gestational diabetes mellitus in northeastern Turkey (Trabzon city). Eur J Epidemiol. 2003; 18: 39-43. 103 - Boz C, Velioğlu S, Altunayoğlu V, Özmenoğlu M, Erem C. Central nervous system involvement in autoimmune polyglandular sydrome. Clin Neurol Neurosurg. 2003; 105: 102-104. 104 - Kavgaci H, Sahin A, Ersoz HO, Erem C, Ozdemir F. The effects of losartane and fosinopril in hypertensive type 2 diabetic patients. Diab Res Clin Prac. 2002; 58: 19-25. 105 - Erem C, Ersoz HO, Kartı SS, Ukinç K, Hacıhasanoglu A, Değer O, Telatar M. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest. 2002; 25: 345-350. 106 - Erem C, Tanakol R, Alagöl F, Ömer B, Çetin Ö. Relationship of Bone Turnover Parameters, Endogenous Hormones and Vit D Deficiency to Hip Fracture in Elderly Postmenopausal Women. Int J Clin Pract. 2002; 56: 333-337. 107 - Erem C, Yildiz R, Kavgacı H, Karahan C, Deger O, Can G, Telatar M. Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city). Diab Res Clin Prac. 2001; 54: 203-208. 108 - Erem C, Kavgaci H, Karahan C, Mocan MZ, Telatar M.Thyroid function tests in pregnant women with and without goiter in the eastern Black Sea region. Gynecol Endocrinol. 2001; 15:293-97. 109 - Celik S, Erdol C, Erem C, Baykan M, Gokce M, Durmus I. Echocardiographic evaluation in patients with hypogonadotropic hypogonadism. J Reprod Med. 2001; 46: 709-11. 110 - Vanizor B, Orem A, Karahan SC, Kiran E, Erem C, Aliyazicioglu R, Uydu HA. Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications. Diabetes Res Clin Pract. 2001; 54:33-39. 111 - Karahan SC, Deger O, Orem A, Ucar F, Erem C, Alver A, Onder E. The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus. Clin Chem Lab Med. 2001;39: 109-15. 112 - S.C Karahan, A. Örem, O. Değer, Erem C, Y. Aliyazıcıoğlu, S. Yildirmiş, F. Özdemir. Plasma Polymorphonuclear elastase: A good indicator for vascular complications in patients with NIDDM ?. Diabetes Research. 2000;35:001-009. 113 - Erem C, Uslu T, Deger O, Tosun M, Kavgaci H. Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events. Heart. 2000; 84 : 208-9. 114 - Erem C, Deger O, Bostan M, Orem A, Sonmez M, Ulusoy S, Telatar M. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications. Acta Cardiol. 1999;54:203-7. 115 - Erem C, Deger O, Bostan M, Orem A, Sonmez M, Ulusoy S, Telatar M. Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects. Acta Cardiol. 1999; 54: 77-81. 116 - Mocan MZ, Erem C, Ulusoy S. Urinary cAMP activity in chronic renal failure. Int Urol Nephrol. 1998; 30: 215-22. 117 - Erem C, Unal M, Serce K, Baki AH, Tufan U, Harova G. What is your diagnosis? Int Urol Nephrol. 1998; 30: 49-51. 118 - Erem C, Kulan K, Tuncer C, Bostan M, Mocan Z, Komsuoglu B. Cardiac arrhythmias in patients on maintenance hemodialysis. Acta Cardiol. 1997; 52: 25-36. 119 - Uslu T, Erem C, Tosun M, Deger O. Plasma endothelin-1 levels in Behcet's disease. Clin Rheumatol. 1997; 16: 59-61. 120 - Erem C, Savaşkan H, Çağılcı F, Değer O, Karahan C, Korkmaz H, Ulusoy Ş, Sönmez M, Cihanyurdu N, Telatar M. Plasma Endothelin-1 Levels in Patients With Type II Diabetes Mellitus. Diabetes Research. 1996; 31: 105-111 121 - Efe H, Erem C, Değer O, Aliyazıcıoğlu Y, Örem A, Yıldırmış S. Plasma Malondialdehyde Levels in NIDDM Patients: Relationship with GlycosylatedHemoglobin and HDL-C. Diabetes Research. 1996 ;31:137-147. 122 - Erem C, Ünal M, Telatar M, Serçe K, Turgutalp H. Insulinoma and Primary Hypothyroidism. Diabetes Research. 1996; 31: 83-90. 123 - Tosun M, Guler M, Erem C, Uslu T, Miskioglu E. Intermittent polyarthritis due to propylthiouracil. Clin Rheumatol. 1995; 14: 574-75. 124 - Mocan MZ, Erem C, Telatar M. Urinary iodine levels in pregnant women with and without goiter in the Eastern Black Sea part of Turkey. Trace Elements and Electrolytes.1995; 12: 195-197. 125 - Unal M, Tuncer C, Serce K, Bostan M, Erem C, Gokce M. A cardiac giant hydatid cyst of the interventricular septum masquerading as ischemic heart disease: role of MR imaging. Acta Cardiol. 1995; 50: 323-6. 126 - Unal M, Tuncer C, Serce K, Bostan M, Gokce M, Erem C. Non-valvular main pulmonary artery vegetation associated with aortopulmonary window. Acta Cardiol. 1995; 50: 241-44. 127 - Erem C, Kulan K, Goldeli O, Tuncer C, Komsuoglu B, Mocan M. Impact of hemodialysis on QT interval. Acta Cardiol. 1995; 50: 177-85. 128 - Unal M, Erem C, Serce K, Tuncer C, Bostan M, Gokce M. The presence of both horseshoe and a supernumerary kidney associated with coarctation of aorta. Acta Cardiol. 1995; 50: 155-60. 129 - Mocan Z, Erem C, Yildirim M, Telatar M, Deger O. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy. Diabetes Res. 1994; 26: 101-7. II-ULUSAL MAKALELER 1 - Cihangir Erem, Nadim Civan, Mehmet Fidan, Ümit Çobanoğlu, Fevzi Kangül, Hülya Coşkun, İdris Yıldız. A clinically silent pheochromocytoma combined with subclinical Cushing’s syndrome in the same adrenal gland: A case report and review of literatüre. Nobel Med 2017; 13(1): 74-80. 2 - Nadim Civan, Cihangir Erem, İrfan Nuhoğlu, Hülya Coşkun, Halil Önder Ersöz, Mustafa Koçak, Asım Örem, Ayşegül Yılmaz. Cardiac troponin I is not increased in severe acute hypothyroidism in patients with differentiated thyroid carcinoma. Nobel Med 2016; 12(3): 47-50. 3 - Ükinç K, Erem C, Ersöz HÖ, Hacıhasanoğlu A, Ersöz Ş, Fidan E. Vaka Sunumu: Prostat Adenokarsinomu ve Ektopik ACTH Sendromu. Turkiye Klinikleri J Med Sci 2006, 26:699- 703 4 - Hacıhasanoğlu AB, Koçak M, Ükinç K, Erem C, Ersöz HÖ, Erdöl H, Telatar M: Primer gonadal yetmezlik ile birlikte seyreden Wolfram Sendromu (Olgu sunumu). Türkiye Klinikleri Endokrinoloji 2(3):213–216;2004. 5 - K. Ükinç, H.Ö. Ersöz, C. Erem, S. Kartı, M. Telatar. Diyabetik hastalarda mikro ve makrovasküler komplikasyonların göstergesi olarak CRP, fibrinojen ve ferrritin düzeyleri. Türk Diyabet Yıllığı 2001-2002. S.199-209. 6 - C.Erem, E. Algün, N. Özbey, A. Azezli, F. Aral, Y. Orhan, S. Molvalılar, E. Sencer. Basedow-Graves hastalığında radyoaktif ilaç tedavisinin sonuçları. İst. Tıp Fak. Mecmuası. 2001; 63 (1): 41-47. 7 - E.A.Çakmak, C.Erem, T.Fıstık, M. Solak, S. Şimşek, Ü.Tufan, H. Savaşkan. Obes olgularda dermoglifik analizler: İlk bulgular. Kocaeli Tıp Dergisi. 2001; 2:95-101. 8 - H. Kavgacı, AH. Baki, C. Erem. Akut böbrek yetmezliğinde yaş prognoz ilişkisi. Klinik Bilimler Doktor. 2000; 6 (2): 161-64. 9 - C.Erem, E. Algün, N. Özbey, A. Azezli, F. Aral, Y. Orhan, S. Molvalılar, E. Sencer. Cushing sendromu: kırk beş olgunun klinik ve laboratuvar bulguları ve tedavi sonuçları ile değerlendirilmesi. İst. Tıp Fak. Mecmuası. 1999; 62 (3): 237-42. 10- M. Adaş, R. Tanakol, S. Yarman, C. Erem, H. Boztepe, F. Alagöl, H. Azizlerli, Ö. Sandalcı. Acil metabolik ve nörolojik hastalıkların ayırıcı tanısında porfiria. İst. Tıp Fak. Mecmuası. 1999; 62 (2): 200-207. 11- H. Kavgacı, A. Baki, C. Erem. Akut böbrek yetmezliğinde prognoza etkili faktörler. TKlin Tıp Bilimleri. 1999; 19: 358-361. 12- C. Erem, Ş. Ulusoy, A. Örem, M. Sönmez, O. Değer, H. Kavgacı. Prediyaliz ve kronik hemodiyaliz hastalarında plazma lipoprotein (a) seviyeleri. Karadeniz Tıp Dergisi. 1999;12: 6-8. 13- C. Erem, R. Tanakol. Tiroid hastalıklarında koagülasyon bozuklukları. Aktüel Tıp Dergisi. 1998; 3(6): 308-12. 14 - T. Uslu, M. Güler, M. Tosun, C. Erem. Clinical characteristics of patients with Ankylosing spondylitis. Türkiye Tıp Dergisi. 1997; 4 29-32. 15- C. Erem, H. Kavgacı, T. Uzun, M. Telatar, K. Serçe. Uyumsuz bir primer hiperparatiroidi vakası. MN Doktor. 1996; 4: 123-26. 16- Ş. Ulusoy, F. Aydın, R. Yıldız, C. Erem. Down sendromu ve akut lösemi (Olgu sunumu). Acta Oncologica Turcica. 1996; 3-4: 148-50. 17- C. Erem, Ş. Ulusoy, E. Ovalı, Z. Mocan, M. Telatar. Kronik Hemodiyaliz Hastalarında Hemostaz ve Hemodiyalizin Hemostaz Üzerine Etkisi. Türk Hematoloji-Onkoloji Dergisi ( THOD). 1996; 6:69-76. 18- T.Uslu, M.Tosun, N. Hansu, C. Erem, M. Güler. Romatoid Artritli ve Fibromiyalji Sendromlu Kadın Hastalarda Kan Testosteron Seviyeleri. Tıbbi Rehabilitasyon Kurumu Derneği. 1996 ;7:85-88. 19- T.Uslu, M.Tosun , C. Erem, N. Hansu, M. Güler. Romatoid Artritli ve Fibromiyalji Sendromlu Kadın Hastalarda Plazma Prolaktin Seviyeleri. Fizik Tedavi ve Rehabilitasyon Derneği. 1996; 7:15-17. 20- C. Erem, E. Akyılmaz, E.Ovalı, Ş Ulusoy, MZ. Mocan. Akut Böbrek Yetersizliği olan hastalarda idrar endotelin eksresyonu. Yeni Tıp Dergisi. 1996; 13: 5- 21- MZ. Mocan, H. Kavgacı, C. Erem, H. Mocan. The Influence of Essential Amino Acid Supplementation for the Improvement of Acute Renal Failure. T J Med Sci .1996; 26: 271-75. 22- MZ. Mocan, B. Çetinarslan, C. Erem, M. Telatar. The Effect of Hyperthyroidism on Renal Function. Turkish Journal of Medical Research. 1995;13:28-30. 23- M. Ünal, C. Erem, K. Serçe, Ö.İleli. Metastatik Kitleleri Taklit Eden Fokal Hepatik Yağlı İnfiltrasyon. Journal of Turgut Özal Medical Center. 1995; 2(2): 196-98. 24- M. Ünal, C. Erem, E. Korkmaz, K. Serçe, M. Kul, A. Zibandeh. Postprandial insufficient emptying of the gallbladder in patients with hypotonic gastroptosis: Role of Ultrasonography. T J Med Sci. 1995;24 119-22. 25- Ş. Ulusoy, C. Erem, B. Kardeş, E. Ovalı, İ. Köksal, Z. Mocan. Kronik Hemodiyaliz Hastalarında HBsAg, anti HBs, anti HCV ve anti HIV Prevalansı. Mikrobiyoloji Bülteni. 1995; 29: 397-403. 26- Ş. Ulusoy, C. Erem, E. Ovalı, M. Yıldırım, M. Sönmez, MZ. Mocan, M. Telatar. Kronik Hemodiyaliz Hastalarında Diyaliz Esnasında ve Diyaliz Dışı Dönemde Nazal Desmopressin'in (DDAVP) Hemostaz Üzerine Etkisi. Türk Hematoloji-Onkoloji Dergisi (THOD).1995; 5:134-142. 27- C. Erem, M. Sönmez, H. Kavgacı, MZ. Mocan, M. Telatar. Akut Böbrek Yetersizliğinde Komplikasyonlar ve Mortalite. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon Dergisi.1995; 2: 106-110. 28- M. Ünal, C. Erem, K. Serçe. Renal Involvement by Lymphoma As A Renal Mass. J Med Sci.1995; 15: 359-60. 29- C. Erem, Y. Bülbül, T. Özlü. Sarkoidoz. Sendrom. 1995;7:18-24. 30- C. Erem, Z. Mocan, M. Telatar, Ş. Ulusoy. Trabzon ve Yöresinde Gebelerde Guatr Prevalansı. Endokrinolojide Yönelişler. 1995; 4:20-23. 31- C. Erem, U. Onur, Z. Mocan, H. Gümele, M. Telatar. Kronik Hemodiyaliz Hastalarında Beyin Manyetik Rezonans Bulguları. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon Dergisi.1995; 3: 118-122. 32- M. Ünal, C. Erem, K. Yıldız, K. Serçe, M. Sönmez. Primary Splenic Lymphoma: Regional Multi-organ İnvasion. T J Med Sci. 1995;23:225-230. 33- M. Ünal, C. Erem, K. Serçe. The Pseudo '' Pseudokidney Sign '' Due To the Mesenteric Tumor. T J Med Sci. 1995;23:159-160. 34- M. Ünal, H. Dinç, K. Serçe, C. Erem, S. Yılmaz. Large Splenic Artery Aneurysm Simulating Pancreatic Tail Carcinoma on Computed Tomography. T J Med Sci.1995;23:247-248. 35- C. Erem, M. Telatar, Y. Uzun, S. Çelik. A case of Secondary Testicular Insufficiency ''Isolated Luteinizing Hormone Deficiency''.T J Med Sci. 1995;23:89-92. 36- M. Ünal, K. Serçe, C. Erem, E. Korkmaz, S. Mızrak, M. Kul. Baryumlu kolon incelemesinde spastik kolonun radyolojik tanı kriterleri. Tanısal ve Girişimsel Radyoloji. 1994; 1:143-147. 37- M. Ünal, T. Uslu, S. Yılmaz, M. Tosun, C. Erem, T. Özlü, K. Serçe. Romatizmal hastalıkların akciğer değişikliklerinde yüksek rezolüsyonlu BT. Tanısal ve Girişimsel Radyoloji. 1994; 1:138-142. 38- M. Ünal, C. Erem, K. Serçe. An Acute Leukemia Case Presenting with Acute Lung Disease on Computed Tomography. T J Med Sci 22 (1994) 203-204. 39- C. Erem, M. Tosun, M. Telatar, M. Güler, K. Serçe, AU. Turhan. Normokalsemi, Brown Tümörü ve Böbrek Taşları ile Seyreden Bir Primer Hiperparatiroidi Vakası. T Klin Tıp Bilimleri 94;14:72-77. 40- C. Erem, Ü. Tufan, Y. Yiğiter, H. Savaşkan. Sigara ve Kanser. MN DOKTOR 1994;2:286-291. 41- C. Tuncer, C. Erem, H. Efe, M. Gül. Tiroid ve Kalp. MN DOKTOR 1994;313-315. 42- C. Erem, C. Tuncer, H. Efe. Antioksidanlar ve Lipid Metabolizması. T Klin Kardiyoloji. 1994;7:121-124. |
|
444 44 61 - For Appointments: 0462 455 64 64 - 0462 455 64 25
+90 (462) 321 36 30
info@imperialhastanesi.com
Kemerkaya Mah. Devlet Sahil Yolu İller sok. No: 21 Trabzon/TÜRKİYE
Phone Numbers for Appointments
455 64 25 • 455 64 64 • 455 64 22
The reason why you preferred our hospital? (463 vote)
|
